Expert consensus on the relevance of intestinal microecology and hematopoietic stem cell transplantation.
graft versus host disease
hematopoietic stem cell transplantation
intestinal microecology
Journal
Clinical transplantation
ISSN: 1399-0012
Titre abrégé: Clin Transplant
Pays: Denmark
ID NLM: 8710240
Informations de publication
Date de publication:
07 Nov 2023
07 Nov 2023
Historique:
received:
25
10
2023
accepted:
27
10
2023
medline:
7
11
2023
pubmed:
7
11
2023
entrez:
7
11
2023
Statut:
aheadofprint
Résumé
Hematopoietic stem cell transplantation (HSCT) affects gut microbial homeostasis, and intestinal microecology (IM) may also affect the prognosis of HSCT through multiple mechanisms. In order to further understand the key issues of the correlation between intestinal microecology and HSCT and to learn and absorb new research progress, the Tumor and Microecology Committee of China Anti-Cancer Association organized relevant experts to discuss together and propose the "Expert Consensus on the Relevance of Intestinal Microecology and Hematopoietic Stem Cell Transplantation" for clinicians' reference in their practical work. It is a reference for clinicians in practice and provides a basis for further in-depth research in the field of tumor and microecology.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e15186Subventions
Organisme : Shenzhen Nanshan District Health System Science and Technology Major Project
ID : NSZD2023018
Informations de copyright
© 2023 The Authors. Clinical Transplantation published by John Wiley & Sons Ltd.
Références
Chatterjee A, Modarai M, Naylor NR, et al. Quantifying drivers of antibiotic resistance in humans: a systematic review. Lancet Infect Dis. 2018;18(12):e368-e378.
Reinhardt C. Themicrobiota: a microbial ecosystem built on mutualism prevails. J Innate Immun. 2019;11(5):391-392.
Noor F, Kaysen A, Wilmes P, et al. The gut microbiota and hematopoietic stem cell transplantation: challenges and potentials. J Innate Immun. 2019;11(5):405-415.
Koliarakis I, Psaroulaki A, Nikolouzakis TK, et al. Intestinal microbiota and colorectal cancer: a new aspect of research. J BUON. 2018;23(5):1216-1234.
Liu W, Zhang R, Shu R, et al. Study of the relationship between microbiome and colorectal cancer susceptibility using 16SrRNA sequencing. Biomed Res Int. 2020;2020:7828392. doi:10.1155/2020/7828392. Published 2020 Jan 30.
Storb R, Prentice RL, Buckner CD, et al. Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment. N Engl J Med. 1983;308(6):302-307.
Jenq RR, Taur Y, Devlin SM, et al. Intestinal Blautia is associated with reduced death from graft-versus-host disease. Biol Blood Marrow Transplant. 2015;21(8):1373-1383.
Guo Z, Gao HY, Zhang TY, et al. Analysis of allogeneic hematopoietic stem cell transplantation with high-dose cyclophosphamide-induced immune tolerance for severe aplastic anemia. Int J Hematol. 2016;104(6):720-728.
Xu L, Chen H, Chen J, et al. The consensus on indications, conditioning regimen, and donor selection of allogeneic hematopoietic cell transplantation for hematological diseases in China-recommendations from the Chinese Society of Hematology. J Hematol Oncol. 2018;11(1):33.
Wang J, Liang J, He M, et al. Chinese expert consensus on intestinal microecology and management of digestive tract complications related to tumor treatment (version 2022). J Cancer Res Ther. 2022;18(7):1835-1844.
Lindner S, Peled JU. Update in clinical and mouse microbiota research in allogeneic haematopoietic cell transplantation. Curr Opin Hematol. 2020;27(6):360-367.
Cario E. Toll-like receptors in the pathogenesis of chemotherapy-induced gastrointestinal toxicity. Curr Opin Support Palliat Care. 2016;10(2):157-164.
Shimasaki T, Seekatz A, Bassis C, et al. Increased relative abundance of klebsiella pneumoniae carbapenemase-producing klebsiella pneumoniae within the gut microbiota is associated with risk of bloodstream infection in long-term acute care hospital patients. Clin Infect Dis. 2019;68(12):2053-2059.
Tanaka JS, Young RR, Heston SM, et al. Anaerobic antibiotics and the risk of graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2020;26(11):2053-2060.
Weber D, Jenq RR, Peled JU, et al. Microbiota disruption induced by early use of broad spectrum antibiotics is an independent risk factor of outcome after allogeneic stem cell transplantation. Biol Blood Marrow Transplant. 2017;23(5):845-852.
Zając-Spychała O, Wachowiak J, Pieczonka A, et al. Bacterial infections in pediatric hematopoietic stem cell transplantation recipients: incidence, epidemiology, and spectrum of pathogens: report of the Polish Pediatric Group for hematopoietic stem cell transplantation. Transpl Infect Dis. 2016;18(5):690-698.
Schuster MG, Cleveland AA, Dubberke ER, et al. Infections in hematopoietic cell transplant recipients: results from the organ transplant infection project, a multicenter, prospective, cohort study. Open Forum Infect Dis. 2017;4(2):ofx050.
Lin Z, Iqbal Z, Ortiz JF, et al. Fecal microbiota transplantation in recurrent clostridium difficile infection: is it superior to other conventional methods? Cureus. 2020;12(8):e9653.
Vaughn JL, Balada-Llasat JM, Lamprecht M, et al. Detection of toxigenic Clostridium difficile colonization in patients admitted to the hospital for chemotherapy or haematopoietic cell transplantation. J Med Microbiol. 2018;67(7):976-981.
Salamonowicz M, Ociepa T, Frączkiewicz J, et al. Incidence, course, and outcome of Clostridium difficile infection in children with hematological malignancies or undergoing hematopoietic stem cell transplantation. Eur J Clin Microbiol Infect Dis. 2018;37(9):1805-1812.
Zhou B, Yuan Y, Zhang S, et al. Intestinal flora and disease mutually shape the regional immune system in the intestinal tract. Front Immunol. 2020;11:575.
Vobořil M, Brabec T, Dobeš J, et al. Toll-like receptor signaling in thymic epithelium controls monocyte-derived dendritic cell recruitment and treggeneration. Nat Commun. 2020;11(1):2361.
Jang GY, Lee JW, Kim YS, et al. Interactions between tumor-derived proteins and Toll-like receptors. Exp Mol Med. 2020;52(12):1926-1935.
Jonsson H, Hugerth LW, Sundh J, et al. Genome sequence of segmented filamentous bacteria present in the human intestine. Commun Biol. 2020;3(1):485.
Liu P, Wang B, Yan X, et al. Comprehensive evaluation of nutritional status before and after hematopoietic stem cell transplantation in 170 patients with hematological diseases. Chin J Cancer Res. 2016;28(6):626-633.
Ilett EE, Jørgensen M, Noguera-Julian M, et al. Associations of the gut microbiome and clinical factors with acute GVHD in allogeneic HSCT recipients. Blood Adv. 2020;4(22):5797-5809.
Fredricks DN. The gut microbiota and graft-versus-host disease. J Clin Invest. 2019;129(5):1808-1817.
Yoshifuji K, Inamoto K, Kiridoshi Y, et al. Prebiotics protect against acute graft-versus-host disease and preserve the gut microbiota in stem cell transplantation. Blood Adv. 2020;4(19):4607-4617.
Kusakabe S, Fukushima K, Yokota T, et al. Enterococcus: a predictor of ravaged microbiota and poor prognosis after allogeneic hematopoietic stem cell transplantation. Biol Blood Marrow Transplant. 2020;26(5):1028-1033.
Shono Y, van den Brink MRM. Gut microbiota injury in allogeneic haematopoietic stem cell transplantation. Nat Rev Cancer. 2018;18(5):283-295.
Parco S, Benericetti G, Vascotto F, et al. Microbiome and diversity indices during blood stem cells transplantation-new perspectives? Cent Eur J Public Health. 2019;27(4):335-339.
Payen M, Nicolis I, Robin M, et al. Functional and phylogenetic alterations in gut microbiome are linked to graft-versus-host disease severity. Blood Adv. 2020;4(9):1824-1832.
Tu S, Zhong D, Xie W, et al. Role of toll-like receptor signaling in the pathogenesis of graft-versus-host diseases. Int J Mol Sci. 2016;17(8):1288.
Zhang F, Zuo T, Yeoh YK, et al. Longitudinal dynamics of gut bacteriome, mycobiome and virome after fecal microbiota transplantation in graft-versus-host disease. Nat Commun. 2021;12(1):65.
Ladas EJ, Bhatia M, Chen L, et al. The safety and feasibility of probiotics in children and adolescents undergoing hematopoietic cell transplantation. Bone Marrow Transplant. 2016;51(2):262-266.
Han H, Yan H, King KY. Broad-spectrum antibiotics deplete bone marrow regulatory T cells. Cells. 2021;10(2):277.
Blaser MJ. Antibiotic use and its consequences for the normal microbiome. Science. 2016;352(6285):544-545.
Pession A, Zama D, Muratore E, et al. Fecal microbiota transplantation in allogeneic hematopoietic stem cell transplantation recipients: a systematic review. J Pers Med. 2021;11(2):100.
Lee YJ, Arguello ES, Jenq RR, et al. Protective factors in the intestinal microbiome against Clostridium difficile infection in recipients of allogeneic hematopoietic stem cell transplantation. J Infect Dis. 2017;215(7):1117-1123.
Schoemans HM, Lee SJ, Ferrara JL, et al. EBMT-NIH-CIBMTR Task Force position statement on standardized terminology & guidance for graft-versus-host disease assessment. Bone Marrow Transplant. 2018;53(11):1401-1415.
Penack O, Marchetti M, Ruutu T, et al. Prophylaxis and management of graft versus host disease after stem-cell transplantation for haematologicalmalignancies: updated consensus recommendations of the European society for blood and marrow transplantation. Lancet Haematol. 2020;7(2):e157-e167.